Almost 1M have died from coronavirus. Their deaths taught researchers about treatment

The nearly 1 million people around the world who have lost their lives to COVID-19 have left us a gift: Through desperate efforts to save their lives, scientists now better … Read More

Wearing a mask may reduce how sick you get from coronavirus

Mask-wearing has become ubiquitous with the coronavirus pandemic. It’s been proven to be a preventative measure to slow the spread of the virus — the main benefit being to protect … Read More

‘Incompetence and dishonesty’: Biden says he trusts vaccines, scientists — not Trump

Joe Biden said Wednesday that while he trusts what scientists say about a potential coronavirus vaccine, he doesn’t trust President Donald Trump. His comments come as the debate over a … Read More

Study sheds light on coronavirus ‘long-haulers,’ but experts still lack clear picture

Months and weeks after falling ill, people worldwide are reporting lingering symptoms of COVID-19. Doctors and researchers believe there are a number of possible explanations as to why the self-described … Read More

How the U.S. wildfires are impacting air quality from B.C. to Ontario

Smoke from U.S. wildfires burning in Washington, Oregon and California has made its way to western Canada and is having visible impacts on air quality in several provinces. Grey skies … Read More

Scientists from 5 countries question accuracy of Russia coronavirus vaccine data

A group of scientists sent a formal letter to the Lancet on Monday outlining doubts about the accuracy of early data on Russia’s COVID-19 vaccine, one of the authors said, … Read More

AstraZeneca to resume coronavirus vaccine trial after unexplained illness in U.K.

Clinical trials testing a potential COVID-19 vaccine developed by AstraZeneca and the University of Oxford are set to resume after a six-day pause due to “potentially unexplained illness” in the … Read More

Why a pause on AstraZeneca’s coronavirus vaccine trial isn’t entirely bad news

The world is waiting with bated breath for a coronavirus vaccine. So when AstraZeneca, a frontrunner in Phase 3 of global trials, unexpectedly hit pause on its study due to … Read More

A Toronto woman contracted coronavirus in March. She’s still exhibiting symptoms

When Susie Goulding was first diagnosed with the novel coronavirus in March, she said she experienced sinus infections, couldn’t swallow, and that her throat felt like “it was paralyzed.” After … Read More

Obesity may up risks of COVID-19 complications, but doctors still searching for why

In the early days of the pandemic, doctors noticed something about the people severely ill from COVID-19: many were obese. The link became more apparent as coronavirus swept across the … Read More

9 drugmaker executives testing coronavirus vaccines pledge safety, high standards

The top executives of nine drugmakers likely to produce the first vaccines against the new coronavirus signed an unprecedented pledge meant to boost public confidence in any approved vaccines. The … Read More

China coronavirus vaccine candidate appears safe for older people: preliminary results

Chinese firm Sinovac Biotech Ltd said on Monday its coronavirus vaccine candidate appeared to be safe for older people, according to preliminary results from an early to mid-stage trial, while … Read More

Study finds coronavirus antibodies last months, offering hope for vaccine efficacy

Antibodies that people make to fight the new coronavirus last for at least four months after diagnosis and do not fade quickly as some earlier reports suggested, scientists have found. … Read More

Ontario researchers make strides in predicting severity of coronavirus in patients

A team from Lawson Health Research Institute and Western University in London, Ont., is reporting groundbreaking discoveries that researchers hope will lead to better outcomes for those seriously ill due … Read More

1st coronavirus reinfection case reported by researchers in Hong Kong

A Hong Kong man who recovered from COVID-19 was infected again four-and-a-half months later in the first documented instance of human re-infection, researchers at the University of Hong Kong said … Read More

Potential COVID-19 vaccine still not in Canada, three months after approval for trials

Shipments of a Chinese and Canadian-developed COVID-19 candidate vaccine remain delayed from getting to Canada, more than three months after Health Canada approved them for Phase 1 trials here. The … Read More

Scientists may have found first human link between antibodies, coronavirus protection

American scientists say they may have found the first evidence of a link in humans between certain antibodies and protection from becoming infected with the coronavirus. The findings — which … Read More

U.S. recruits scientists abroad to test COVID-19 vaccine candidates, pledges access to doses

WASHINGTON — The Trump administration’s coronavirus vaccine project is recruiting scientists in South Africa and Latin America to help test possible vaccines in U.S.- backed clinical trials, pledging to ease … Read More

Why the hunt for a coronavirus vaccine is the new space race

No, Russia isn’t having a Sputnik moment. The announcement Tuesday by Russian President Vladimir Putin that his country was the first to approve a coronavirus vaccine did not provoke the … Read More

Should e-cigarettes be banned amid coronavirus? Why some U.S. lawmakers are pushing for it

A Stanford University study found those who vaped were five times more likely to be diagnosed with the novel coronavirus than non-users, prompting some United States lawmakers to try to … Read More

Coronavirus: Mexico to conduct phase 3 trials for China, U.S. vaccine candidates

MEXICO CITY — Mexico will conduct late-stage clinical trials for COVID-19 vaccines in development by Johnson & Johnson and two Chinese companies, the foreign ministry said on Tuesday. Large-scale, phase … Read More

Coronavirus: Concerns over global drug shortage prompts London, Ont., sedatives study

As the possibility of a second wave of COVID-19 in the fall raises increased concern over the potential for global drug shortages, a team out of Lawson Health Research Institute … Read More

New Canadian clinical guidelines first to include chapter on weight stigma

For the first time, Canadian Clinical Practical Guidelines for adult obesity management will include a chapter on weight bias and stigma. Dr. Sara Kirk, a professor of Health Promotion at … Read More

Data and demographics: Is the COVID-19 death rate lower in the developing world?

A report published in India in July revealed some worrying numbers on the prevalence of COVID-19 in some of Mumbai’s slums. It estimated that around 57 per cent of people … Read More

U.S. drops another $2.1B for doses of experimental coronavirus vaccine candidate

LONDON — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an experimental COVID-19 vaccine to the United States as governments buy up supplies … Read More

Vitamin D and COVID-19: Experts say any possible link is ‘premature’

Aside from a potential vaccine, there’s no surefire answer to COVID-19. Scientists agree on the basic hygiene principles to avoid infection as well as on the primary way the virus … Read More

Poor sleep tied to multiple chronic conditions: Western University study

How well and how long a person sleeps is tied to how likely they are to live with multiple chronic conditions, according to researchers at Western University in London, Ont. … Read More

Dogs might be able to sniff out COVID-19, study suggests

With just one week of training, a pack of dogs in Germany has learned how to detect COVID-19 in human samples. Researchers with a German veterinary university trained eight dogs … Read More

Ontario nurse under investigation over anti-mask, conspiracy theory Facebook posts

The head of the Registered Nurses Association of Ontario (RNAO) is describing the controversial views reportedly expressed by a local nurse practitioner — now under investigation — as “the most … Read More

Coronavirus antibodies decay fast, but that doesn’t mean protection is gone: study

New research suggests that antibodies the immune system makes to fight the new coronavirus may only last a few months in people with mild illness, but that doesn’t mean protection … Read More

Canadian-led study to examine antibodies from recovered COVID-19 patients as treatment for others

A new multi-centre study, led by Canadian researchers, will look at whether blood plasma from people who have recovered from COVID-19 can help current patients fight off the illness. Among … Read More

Adults should limit themselves to 1 alcoholic drink per day, experts say

If you decide to have an alcoholic drink, limiting yourself to one a day is best — whether you’re a man or woman. That’s the new advice experts are recommending … Read More

B.C. man could be Canada’s first double-hand transplant recipient

When Rick Thompson’s doctor told him a surgical team was going ahead with his double-hand transplant in the middle of the COVID-19 pandemic, his first reaction was surprise. “We’re targeting … Read More

China’s CanSino in talks for large-scale trial of potential coronavirus vaccine overseas

Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine, its co-founder said on … Read More

Coronavirus drug approved for use in India on patients with moderate to severe symptoms

India’s Biocon Ltd has received regulatory approval for its drug Itolizumab to be used on coronavirus infected patients suffering from moderate to severe respiratory distress, the biopharmaceutical company said in … Read More

UBC study suggests dying people can still hear in their final hours

Researchers at the University of British Columbia have found evidence that dying people may still be able to hear in the final hours of their lives. The research was published … Read More

Bill Nye the Science Guy returns for ‘wear a mask!’ PSA on coronavirus

Consider the following: Bill Nye is so fed up with people rejecting face masks that he came out of retirement for a new “Science Guy” video about the benefits of … Read More

Coronavirus: Canadian experts say not to get hung up on term ‘airborne’ transmission

A group of 239 scientists and physicians urging the World Health Organization to recognize the potential for airborne transmission of the novel coronavirus have sparked debate over how COVID-19 is … Read More

London, Ont., study examines treatment for premature babies for use in COVID-19 patients

Researchers at Lawson Health Research Institute are looking to see if a particular lipid and protein mixture currently used to help improve lung function in premature babies can be used … Read More

Hospitals develop guidelines to help staff deal with stress, PTSD amid coronavirus

Health-care workers on the front lines of the COVID-19 pandemic are at risk of severe stress that could cause long-term psychological damage, the Centre of Excellence on Post-Traumatic Stress Disorder … Read More

Reality check: Bubonic plague is nothing new, nor is it a risk to Canadians

In 2020, news of a bubonic plague outbreak (while fitting) is stirring up new dread. “Welp, here’s to July… bubonic plague,” said one Twitter user, as the hashtag started trending … Read More

Scientists warn coronavirus could be airborne — What does this mean for Canadians?

Hundreds of scientists are sounding the alarm over the possibility that the novel coronavirus may spread through the air more than we once thought. On Saturday, the New York Times … Read More

Only half of children with HIV are getting treatment due to coronavirus: UN report

New numbers on the global AIDS epidemic show some big successes, such as fewer deaths and new infections. But there are also some tragic failures: Only half the children with … Read More

Research underway in N.S., N.B. to develop new coronavirus-killing package coating

Researchers in Nova Scotia and New Brunswick are collaborating on a way to reduce the transmission of the novel coronavirus on the surfaces of items we touch in our daily … Read More

U.S. buys up worldwide stock of remdesivir, drug seen as potential COVID-19 treatment

The United States has secured nearly the entire worldwide supply of remdesivir, a drug that’s proven effective for severely ill patients of the novel coronavirus — leaving hardly any for … Read More

At least 285 U.S. children developed inflammatory condition linked to COVID-19: study

At least 285 U.S. children have developed a serious inflammatory condition linked to the coronavirus and while most recovered, the potential for long-term or permanent damage is unknown, two new … Read More

China green lights coronavirus vaccine candidate for use on its military

China’s military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and showed some … Read More

Coronavirus drug remdesivir to cost $2,340 per patient in the U.S.

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government … Read More

Risk of never fully recovering after coronavirus ‘very real,’ scientists say

Scientists are only starting to grasp the vast array of health problems caused by the novel coronavirus, some of which may have lingering effects on patients and health systems for … Read More

London, Ont., researchers the first to profile immune response to COVID-19

In a world-first, researchers out of Lawson Health Research Institute and Western University in London, Ont., have profiled the immune system’s response to COVID-19 and identified six molecules they believe … Read More